This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Boster
product type :
antibody
product name :
Anti-IL1 beta Antibody
catalog :
A00101-3
quantity :
100 ug
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
clone name :
polyclonal
reactivity :
mouse
application :
western blot, immunohistochemistry, immunocytochemistry, immunoprecipitation, flow cytometry
product information
SKU :
A00101-3
Product Name :
Anti-IL1 beta Antibody
Size :
100 ug
Clonality :
Polyclonal
Host :
Rabbit
Reactivity :
Mouse, Rat
Application(s) :
Flow Cytometry, IP, IF, IHC, WB
Application Details :
IF Microscopy: 1:50-1:250. Flow Cytometry: User Optimized. Western Blot: 1:500 - 1:2,000. Immunohistochemistry: 1:50-1:250. ImmunoPrecipitation: 1:200-1:800. Other Dilution: User Optimized
Description :
Boster Bio Anti-IL1 beta Antibody catalog # A00101-3. Tested in Flow Cytometry, IP, IF, IHC, WB applications. This antibody reacts with Mouse, Rat.
Concentration :
0.5-1mg/ml, actual concentration vary by lot. Use suggested dilution ratio to decide dilution procedure.
Gene Name :
Il1b
Uniprot ID :
P10749
Form :
Lyophilized
Contents :
0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2
Storage :
Store Anti-IL-1 beta antibody at 4° C prior to restoration. For extended storage aliquot contents and freeze at -20° C or below. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use.
Research Category :
Atherosclerosis, Cardiovascular, Cytokines, Immunology, Innate Immunity, Interleukins, Metabolism, Obesity, Vascular Inflammation
company information
Boster
3942 B Valley Ave
Pleasanton, CA 94566
Pleasanton, CA 94566
boster@bosterbio.com
https://www.bosterbio.com925.485.4527
headquarters: USA
Premium Provider of Antibodies and ELISA Kits
questions and comments